An introduction to Astellas

VISION: On the forefront of healthcare change to turn innovative science into VALUE for patients.

text

Astellas at a glance

test

Headquartered in Tokyo, Japan with operations in more than 70 countries and areas

test

Global employee base of more than 14,500+ people

test

Global revenue in FY23 of ¥ 1,603.7 Billion ($ 11.06 Billion)

test

On-market portfolio includes transformative therapies in oncology, ophthalmology, urology, immunology, and women's health

test

18% of sales revenue invested into R&D programs to pioneer new healthcare solutions in disease areas with high unmet medical need

test

A commitment to collaboration with partners around the world to drive advancements in science and healthcare

Keep exploring

test

Leadership

Meet our Top Management team and Board of Directors.

test

Corporate Strategic Plan

Our Corporate Strategic Plan (CSP2021) is a set of guiding principles and strategies that enables us realize our VISION.

test

Our history

In 2025, Astellas celebrated its 20th anniversary. Learn more about our history as a company.

test

Patient centricity

Astellas supports the development of healthcare solutions through a deep understanding of the patient experience, medical needs and behavioral drivers of care.

test

Digital transformation

Astellas strives to maximize VALUE for patients by implementing digitally-powered solutions across our ecosystem.

test

Sustainability

Learn about Astellas’ commitment to improve access to health and environmental sustainability around the world.

Learn about Astellas’ commitment to improve access to health and environmental sustainability around the world.